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Purpose. Intravascular injection rates are higher during traditional S1 transforaminal epidural steroid injection (TFESI) compared
with lumbar transforaminal injection. We compared the incidences of intravascular injection between the medial and lateral
approaches to the S1 foramen during S1 TFESI.Materials and Methods. A total of 139 patients underwent one or more TFESIs (170
total injections). The patients received S1 TFESI by either medial or lateral side of S1 foramen under fluoroscopic anteroposterior
view using digital subtraction method. The intravascular injection rates, epidural spread patterns, and contrast volumes required
to reach the superior aspect of the L5-S1 intervertebral disc (SIVD) were compared between groups. Results. Intravascular injection
rates during S1 TFESI were significantly lower in the medial approach compared with the lateral approach patients (4.9% versus
38.6%, resp., 𝑃 < 0.001). The medial approach group had more epidural spread to the L5-S1 SIVD than the lateral group (82.1%
versus 58.8%, resp.); lower contrast volume amounts were required to extend the L5-S1 SIVD (1.46 ± 0.48 versus 1.90 ± 0.62, resp.).
Conclusion. During S1 TFESI, approaching the needle towards the medial part of the S1 foramenmay reduce intravascular injection
risk.
1. Introduction
Lumbosacral transforaminal epidural steroid injection
(TFESI) is an important tool for the nonsurgicalmanagement
of lumbosacral radiculopathy [1]. However, the needle may
commonly be misplaced during these procedures, and
incorrect placement of the needle into the spinal vasculature
increases the risk of complications and decreases efficacy.
The incidence of intravascular injection during TFESI is
higher for sacral spine (16.5% to 27.8%) compared with
lumbar area (6.1% to 17.7%) injections [2–4].
Traditionally, S1 TFESI has been performed using an
anteroposterior (AP) view. In 2007, an oblique view technique
using the S1 “Scotty dog” was introduced as an alternative
approach by Fish et al. [5]. This approach reduces procedure
length and radiation exposure, especially when simultaneous
L5 and S1 transforaminal epidural injections are performed.
Fish and coauthors also proposed that misplacement of the
needle tip anterior to the ventral foramen could be avoided
using this approach. Our previous study revealed that, com-
pared with the AP view approach, another advantage of the
Scotty dog is the reduction of the intravascular injection rate
(29% versus 11%, resp.) [6].
During the Scotty dog approach, the block needle arrives
at the sacral epidural space at an inward angle oblique to the
sagittal plane. Therefore, the final needle tip location is at the
more medial part of the S1 foramen. We hypothesized that
while performing the S1 TFESI in the AP view, locating the
needle at the medial side of S1 foramen might decrease the
incidence of intravascular injection, similar to the Scotty dog
approach.
The results of previous studies have indicated that because
the vascular contrast pattern appears and disappears quickly
during TFESI, live fluoroscopy should be used to observe the
dynamic contrast flow [7]. Digital subtraction angiography
(DSA) is also useful for interventional spine fluoroscopy
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Figure 1: Needle tip target for the medial approach and the lateral
approach. Posterior S1 neural foramen (circle). L5-S1 SIVD, superior
aspect of the L5-S1 intervertebral disc (line).
procedures. DSA is very effective when used to increase the
contrast between vascular structures and adjacent soft tissue
and bone [8, 9].
Themain objective of this studywas to compare the values
for incidence of intravascular injection for the medial side
versus the lateral side approaches to the S1 foramen during
S1 TFESI using live fluoroscopy and DSA.The patterns of the
epidural spread of the contrast medium were also compared
between the medial and lateral approaches, and contrast
volumes required for therapeutic S1 TFESI were identified.
2. Methods
2.1. Study Population and Randomization. The institutional
review board approved the protocol for this randomized
prospective clinical trial (reference number 4-2016-0442;
ClinicalTrials.gov reference number NCT02867046). Before
enrollment in the study, informed written consent was
obtained from each patient who received S1 TFESI (139
patients, 20–80 years of age).The patients were enrolled from
our outpatient department for pain management between 15
August 2016 and 31 December 2016. Only patients scheduled
for an S1 TFESI procedure were included in the study
population. A patient was not included in the study if any
of the following were present: pregnancy, anatomical sacral
abnormality (lumbarization or sacralization), known or sus-
pected coagulopathy, systemic infection, any active injection
site infection, or a history of allergy to TFESI injectates
(e.g., contrast media, local anesthetics, or corticosteroids).
Because of an increased risk of postinjection contrast-
induced nephropathy, an estimated glomerular filtration rate
< 45mL/min/1.73/m2 was also an exclusion condition.
Each patient was assigned to the medial or to the lateral
approach group using a computer-generated randomization
protocol. The S1 TFESI was then given to each patient based
on group assignment (Figure 1). The S1 site injection was the
first injection given if the patient also receivedTFESIs at other
levels of the spine.
2.2. Transforaminal Epidural Injections in S1 and Clinical Data
Measures. Fluoroscopic guidance (Siemens Arcadis Varic,
SiemensAktiengesellschaft, Frankfurt, Germany)was used to
direct the TFESI at the S1 neural foramen. Patient placement
included a prone position, a pillow placed under the lower
abdomen, and a sterile drape. A slight cephalad-caudad
tilt (image intensifier caudad) was used to maximize the
fluoroscopic anatomy opening of the neuroforamen in the
AP view (Figure 2). After the skin was infiltrated using 1%
lidocaine, a spinal needle (22G, 8 cm Quincke) was inserted
into the medial or lateral side of the S1 neuroforamen using
intermittent fluoroscopic guidance. Final advancement was
verified using fluoroscopic lateral and AP views. The needle
was then attached to an extension tube, and a syringe (5mL)
was connected to the opposite end of the tube. A blood
aspiration test was then performed. If it was negative, 1mL
contrast medium was slowly injected (0.1ml/sec); DSA was
used to check for intravascular injection. Appearance and
immediate disappearance of a contrast medium snake-flow
spread pattern indicated that intravascular injection had
occurred. At occurrence, each spread pattern was assigned
to one of three categories (i.e., epidural only, epidural and
vascular, and vascular only). If vascular spread of the contrast
medium was observed, the needle was relocated and lack
of vascular uptake was confirmed. If no vascular flow was
observed, real-time fluoroscopy was used to guide continued
injection of the contrast medium until a total volume of
3ml was given. The volume of contrast medium required to
reach L5-S1 SIVD (Figure 2) was recorded [10]. A lidocaine
injection (3ml, 0.5% with 5mg dexamethasone disodium
phosphate) was given at the end of the procedure.
Three experienced physicians participated in this study.
The physician who performed the procedure had experience
with C-arm fluoroscopy-guided injections in more than
2000 cases. The vascular spread of contrast medium was
confirmed by the other physicians who were not performing
the procedure. These physicians also checked the volumes of
contrast medium required to reach the specified landmarks
during live fluoroscopy.
Data on patient and procedure characteristics were
recorded for each patient (e.g., diagnosis, age, sex, body
mass index (BMI), side of the procedure, lumbosacral spine
surgery history including L5-S1 level surgeries, and underly-
ing disease).
2.3. Statistical Analysis. The results of our previous study
revealed a 29% incidence of intravascular injection for cases
of approach to the S1 foramen in AP view [6]. We considered
a 60% decrease in intravascular injection rate in the medial
approach to the S1 foramen during S1 TFESI to be clinically
relevant. Our statistical power analysis results indicated
a required sample size of 85 for each group (𝛼-error =
0.05, power = 80%, and dropout rate = 10%). All results
were expressed as mean ± standard deviation or median
(interquartile range) values or as number of patients. The
Shapiro-Wilk test was used to determine whether the data
were consistent with a normal distribution. Demographic
and clinical data were compared between the two groups
using the t-test or Chi-square test as appropriate.Multivariate
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Figure 2: Spinal landmarks and epidural contrast spread patterns viewed using fluoroscopy during S1 transforaminal epidural steroid
injection, posterior S1 neural foramen (circle); (a) and (b), medial approach to the S1 foramen in anteroposterior (AP) view, note the spread
of medium into the epidural space; (c) and (d), lateral approach to the S1 foramen in AP view.
logistic regression analysis was used to assess possible factors
(e.g., age, sex, diagnosis, BMI, and spine surgery history).
The Statistical Package for the Social Sciences 23 (SPSS Inc.,
Chicago, IL, USA) application was used for all analyses. A
result with a 𝑃 value < 0.05 was considered to be statistically
significant.
3. Results
Data from 170 S1 TFESIs performed on 139 patients (31 bilat-
eral injections) were analyzed. During the procedures, the
oblique view instead of the AP view was used for one patient
from each group because of the difficulty locating the fora-
men. For two cases in the medial group and one case in the
lateral group, it was impossible to distinguish the side of the S1
foramen because of the small size of the posterior S1 foramen.
These five patients were excluded from the study population;
data from a total of 82medial group and 83 lateral group cases
were analyzed (Figure 3). The results for patients’ character-
istics and baseline clinical data are presented in Table 1.
The results obtained using DSA with contrast confirma-
tion indicated that the overall intravascular injection rate
was 4.9% (4/82) in the medial group and 38.6% (32/83)
in the lateral group (Table 2). The values for incidence of
simultaneous epidural and vascular injection during S1 TFESI
were 100% (4/4) in the medial approach group and 41%
(13/32) in the lateral approach group, among the cases that
included vascular injection during the procedure.
The results for the epidural spread patterns of contrast
medium and the respective volumes of contrast medium
required to reach a specific epidural spread pattern landmark
are presented in Table 3. Analysis of only epidural spread
cases revealed that a higher percentage of medial group cases
reached the L5-S1 SIVD, compared with the lateral group
(82.1% versus 58.8%, resp.). The medial approach group pa-
tients required significantly lower contrast medium volumes
to extend to the L5-S1 SIVD, compared with the lateral ap-
proach group patients (1.46 ± 0.48 versus 1.90 ± 0.62, resp.).
The results of the multivariate logistic regression analysis
are presented in Table 4. Compared with the other variables,
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Table 1: Results for characteristics of patients and baseline clinical variables.
Group M (𝑛 = 82) Group L (𝑛 = 83) 𝑃 value
Female 40 (48.8%) 49 (59%) 0.186
Age, years 63.63 ± 11.67 62.07 ± 15.69 0.470
BMI, kg/m2 24.32 ± 2.57 23.93 ± 2.39 0.317
Side
Right 41 (50%) 35 (42.2%) 0.313
Left 41 (50%) 48 (57.8%) 0.313
Diagnosis
Spinal stenosis 49 (59.8%) 44 (53.0%) 0.382
HLD 15 (18.3%) 22 (26.5%) 0.206
FBSS 5 (6.1%) 10 (10.8%) 0.274
Spinal stenosis and HLD 11 (13.4%) 7 (8.4%) 0.305
Previous surgery 16 (19.5%) 17 (20.5%) 0.876
Values are expressed as the mean ± standard deviation or number of patients (%). Group M, medial approach group; Group L, lateral approach group; HLD,
herniated lumbar disc L5-S1; FBSS, failed back surgery syndrome.
Analysed (n = 82)
(i) Excluded from analysis (n = 0) 
Did not complete the procedure (n = 3)
(i) Difficult case in the AP view (n = 1)
(ii) Small S1 foramen (n = 2)
Medial approach group (n = 85)
Did not complete the procedure (n = 2)
(i) Difficult case in the AP view (n = 1)
(ii) Small S1 foramen (n = 1)
Lateral approach group (n = 85)
Analysed (n = 83)
(i) Excluded from analysis (n = 0) 
Allocation
Analysis
Follow-up 
Randomized (n = 170)
Enrollment 170 S1 TEFESI (139 patients)
Figure 3: CONSORT flow diagram.
a lateral side approach to the S1 foramen was the strongest
predictor of intravascular injection during S1 TFESI (odds
ratio = 12.874, 95% confidence interval (CI) = 4.063–40.793,
𝑃 < 0.001). Patient’s sex, age, BMI, diagnosis, and prior
surgery did not have statistically significant association with
incidence of intravascular injection (Table 4).
4. Discussion
The analysis revealed that, during S1 TFESI, the incidence
of intravascular injection in the medial approach group was
significantly lower comparedwith the lateral approach group.
Spread of contrast medium to L5-S1 SIVD was also more
effective in the medial approach group.
The reason for the lower intravascular uptake incidence
in the medial group compared with the lateral group is
unclear. However, the same proposal for the lower incidence
of intravascular uptake during the S1 Scotty dog approach
compared with conventional AP view approach likely con-
tributes to this finding [6]. The decreased vascular uptake
incidence using the oblique Scotty dog approach could be
explained using Sullivan et al.’s hypothesis [11] regarding the
higher incidence of vascular uptake during conventional AP
view S1 transforaminal epidural block, compared with the
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Table 2: Incidence of intravascular injection during S1 transforaminal epidural steroid injection.
Group M (𝑛 = 82) Group L (𝑛 = 83) 𝑃 value
Epidural only, 𝑛 78 (95.1%) 51 (61.4%) <0.001∗
All vascular, 𝑛 4 (4.9%) 32 (38.6%) <0.001∗
Epidural and vascular 4 (4.9%) 13 (15.7%) 0.023∗
Vascular only 0 19 (22.9%) <0.001∗
Values are expressed as the mean ± standard deviation or number of patients (%). Group M, medial approach group; Group L, lateral approach group; SIVD,
superior aspect of the L5-S1 intervertebral disc. ∗𝑃 value < 0.05.
Table 3: Numbers of patients for whom contrast medium reached
an L5-S1 SIVD in epidural only group and volume of contrast
medium required for spread to L5-S1 SIVDduring S1 transforaminal
epidural steroid injection.
Group M
(𝑛 = 78)
Group L
(𝑛 = 51) 𝑃 value
Spread to L5-S1 SIVD, 𝑛 64 (82.1%) 30 (58.8%) 0.004∗
Volume of contrast
medium, mL 1.46 ± 0.48 1.90 ± 0.62 0.001
∗
Values are expressed as the mean ± standard deviation or number of patients
(%). Group M, medial approach group; Group L, lateral approach group;
SIVD, superior aspect of the L5-S1 intervertebral disc. ∗𝑃 value < 0.05.
Table 4: Logistic regression analysis of potential factors associ-
ated with intravascular injection during S1 transforaminal epidural
steroid injection.
OR (95% CI) 𝑃 value
Lateral approach 12.874 (4.063–40.793) <0.001∗
Female 1.613 (0.659–3.950) 0.296
Age 1.021 (0.982–1.061) 0.300
BMI 0.911 (0.766–1.083) 0.289
Diagnosis
Spinal stenosis 0.136 (0.007–2.638) 0.188
HLD 0.322 (0.019–5.540) 0.435
FBSS 0.077 (0.002–2.416) 0.145
Spinal stenosis and HLD 0.086 (0.003–2.336) 0.145
Previous surgery 2.422 (0.646–9.072) 0.189
Values are number (95%CI). HLD, herniated lumbar disc L5-S1; FBSS, failed
back surgery syndrome. ∗𝑃 value < 0.05.
lumbar area. The needle can potentially be positioned along
the vessel’s path during AP view S1 TFESI, especially when it
is in a posterolateral position near the longitudinal vein (part
of the posterior internal vertebral venous plexus). Therefore,
we speculated previously that, by adopting the oblique Scotty
dog approach at the S1 level (approach similar to the lumbar
level approach), the rate of intravascular uptake rate would
be reduced similarly to the lumbar level by avoiding the
posterolaterally located longitudinal veins. During the Scotty
dog approach, the block needle arrives at the sacral epidural
space at an inward angle oblique to the sagittal plane, so the
needle tip will be located at the more medial part of the S1
foramen. Therefore, we hypothesized that while performing
an AP view S1 TFESI, locating the needle at the medial
side of the S1 foramen might decrease the incidence of
intravascular injection in a manner similar to that of the
Scotty dog approach. The lower incidence of vascular uptake
in the medial approach group patients may be explained
by the lower possibility of contact with the posterolateral
longitudinal veins.
The reason that contrast medium spread was more
effective in the medial group remains to be determined.
Epidural spread after S1 TFESI may not be affected by only
the needle approach method used, because epidural spread
patterns are affected by many variables (e.g., variations in
anatomy such as foramen size and formation of postsurgical
adhesions, coexisting spinal pathology such as disc pathology
and spinal stenosis, and the medical history of the patient).
Furthermore, significance of the injectate spread to the disc
pathology level cannot be drawn by this observation only.
We encountered some technical problems while per-
forming this study. In some cases, we could not distinguish
the medial side from the lateral side because of small
foramen size. Occasional minute hemorrhage occurred when
the needle contacted unrecognized bony structures (e.g.,
osteophytes) because the needle approached the edge of the
foramen [12]. We did not record data for paresthesia caused
by nerve contact, but it was not a problem in either group.
The needle was carefully guided as its tip passed through the
posterior foramen.
There were some limitations of this study. During the
procedure, the physician performing the procedure and the
physicians viewing the epidurogram could not be blinded to
the side (i.e., medial versus lateral) of the needle approach.
Because we did not investigate postprocedure improvement
in symptoms such as pain reduction, the results of this study
did not provide information on clinical outcomes.
5. Conclusion
Although the S1 Scotty dog approach has some advantages,
including a lower incidence of vascular uptake, conventional
AP approaches are frequently used because of technical
familiarity or because sometimes the S1 Scotty dog cannot be
clearly seen. This study revealed that when the AP approach
is used, introducing the needle at the medial side of the S1
foramen will result in a decreased incidence of intravascular
uptake and more effective spread of the contrast medium.
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